Creative Biolabs Bispecific Antibody Blog

Menu

Skip to content
  • Bispecific Antibody Research
  • Bispecific Antibody Clinic
  • News

Monthly Archives: June 2023

28Jun/23

Researchers Have Found That PD-L1 Methylation Is a Key Mechanism for Immune Therapy Resistance

June 28, 2023Cancer ImmunotherapyImmune Therapy, PD-L1biobsab

The PD-1/PD-L1 pathway, a critical immune checkpoint in the human body, is influenced by numerous regulatory factors, ranging from genetic mutations and variations to gut microbiota, as well as various factors insideRead More…

Categories

  • Bispecific Antibody Clinic
  • Bispecific Antibody Research
  • BSAB
  • Cancer Immunotherapy
  • Events
  • News

Recent Posts

  • ISB 1442: A Novel Bispecific Antibody for Targeting CD38+ Hematologic Malignancies
  • Advancing HIV-1 Therapy: Bispecific Antibodies to Enhance Latent Reservoir Clearance
  • Unveiling a New Mechanism: How CD47 Shields Cancer Cells from Immune Clearance
  • New Cancer Therapy Target May Disrupt Shared Resources Among Tumor Cells
  • Natural Products Targeting Tumor Angiogenesis

Archives

  • March 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • February 2022
  • March 2021
  • December 2020
  • October 2020
  • August 2020
  • June 2019
  • April 2019
  • March 2019
  • February 2019
  • December 2018
  • November 2018
  • October 2018

Contact Us

USA - UK
Copyright © Creative Biolabs Bispecific Antibody Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Bispecific Antibody Research
  • Bispecific Antibody Clinic
  • News